HeXembio

New York, NY · Founded 2024 · Privately Held (backing)

Developer of a cell restoration technology designed to enable longevity. HeXembio is based in New York, NY and was founded in 2024. Its last reported valuation was $25 million in Mar 2025. It has raised $19.8 million.

Last reported valuation
$25.0M
Oct 2026
Priced at
—
Total raised
$19.8M
Last round
—

Who backs HeXembio?

23 investors
InvestorType
Alumni VenturesVenture capital
SOSVVenture capital
GaingelsVenture capital
Draper AssociatesVenture capital
IndieBioOther
Innovation WorksVenture capital
Seraphim SpaceVenture capital
New York VenturesVenture capital
Wilson Sonsini Goodrich & RosatiOther
ZAKA VCVenture capital
+ 13 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

HeXembio investors

23 investors are on record for HeXembio, including Alumni Ventures, SOSV, Gaingels and Draper Associates. By type, the record holds 8 venture capital firms and 1 growth equity firm.

Free account
More of HeXembio with a free account
  • ·The complete investor list: 23 names
  • ·Watch HeXembio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 23 firms already write checks for companies like HeXembio. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View